Femasys (FEMY) said Thursday it received CE Mark certifications for four of its women's health products, certifying that the products comply with new European Union regulations for medical devices.
The company said the CE Mark approvals come on the heels of the products' European Union Medical Device Regulation certificates and will pave the way for the start of product commercialization in Europe.
Shares of Femasys were up more than 14% in recent early Thursday trading.
Price: 1.09, Change: +0.14, Percent Change: +14.14
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments